AR013803A1 - Forma cristalina del acido (r)-3-[[(4-fluorfenil)sulfonil]amino]-1,2,3,4- tetrahidro-9h-carbazol-9-propanoico (ramatroban), proceso para su preparacion,su uso para la manufactura de un medicamento y medicamento que la contiene - Google Patents
Forma cristalina del acido (r)-3-[[(4-fluorfenil)sulfonil]amino]-1,2,3,4- tetrahidro-9h-carbazol-9-propanoico (ramatroban), proceso para su preparacion,su uso para la manufactura de un medicamento y medicamento que la contieneInfo
- Publication number
- AR013803A1 AR013803A1 ARP980106318A ARP980106318A AR013803A1 AR 013803 A1 AR013803 A1 AR 013803A1 AR P980106318 A ARP980106318 A AR P980106318A AR P980106318 A ARP980106318 A AR P980106318A AR 013803 A1 AR013803 A1 AR 013803A1
- Authority
- AR
- Argentina
- Prior art keywords
- medicinal product
- thermodynamically stable
- ramatroban
- manufacture
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Forma cristalina de ramatroban que es la modificacion I termodinámicamente estable del compuesto activo ramtroban; proceso para su preparacion, su usopara la manufactura de un medicamento y medicamento que la contiene. La forma termodinámicamenteestable se prepara mediante la fusion de la forma metastabley subsiguiente recristalizacion o sembrando una solucion del compuesto activo metastable con un cristal para sembrar de la forma termodinámicamente estable.El compuesto activo termodinámicamente estable puede ser empleado como un agente para el asma. La forma cristalina termodinámicamente estable tiene unpunto de fusion de 151*C (CED, 2 Kmin-1), su difractograma de rayos X tiene reflexiones a 10,1; 12,0 y 19,8 (2theta), su espectro de IR tiene picos máximosa 3338 cm-1, 1708 cm-1 y 1431 cm-1, su espectro de 13CRMN en estado solido tiene picos máximos a 107,9; 118,2 y 135,0 ppm; su espectro FIR tiene un picomáximo de 264 cm-1 y en 207 cm-1; su espectro Raman tiene picos máximos de 3080 cm-1 y 122 cm-1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19757983A DE19757983A1 (de) | 1997-12-24 | 1997-12-24 | Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013803A1 true AR013803A1 (es) | 2001-01-10 |
Family
ID=7853457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980106318A AR013803A1 (es) | 1997-12-24 | 1998-12-11 | Forma cristalina del acido (r)-3-[[(4-fluorfenil)sulfonil]amino]-1,2,3,4- tetrahidro-9h-carbazol-9-propanoico (ramatroban), proceso para su preparacion,su uso para la manufactura de un medicamento y medicamento que la contiene |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US6362214B1 (es) |
| EP (1) | EP1051398B1 (es) |
| JP (2) | JP3817668B2 (es) |
| KR (1) | KR100586350B1 (es) |
| CN (1) | CN1140510C (es) |
| AR (1) | AR013803A1 (es) |
| AT (1) | ATE263152T1 (es) |
| AU (1) | AU744242B2 (es) |
| BG (1) | BG65024B1 (es) |
| BR (1) | BR9814496A (es) |
| CA (1) | CA2313230A1 (es) |
| CO (1) | CO4970800A1 (es) |
| DE (2) | DE19757983A1 (es) |
| DK (1) | DK1051398T3 (es) |
| ES (1) | ES2218874T3 (es) |
| GT (1) | GT199800198A (es) |
| HK (1) | HK1034517A1 (es) |
| HN (1) | HN1998000186A (es) |
| HU (1) | HUP0004432A3 (es) |
| ID (1) | ID25446A (es) |
| IL (1) | IL136278A (es) |
| IN (1) | IN192932B (es) |
| MY (1) | MY116312A (es) |
| NO (1) | NO316618B1 (es) |
| NZ (1) | NZ504741A (es) |
| PE (1) | PE20000115A1 (es) |
| PL (1) | PL341359A1 (es) |
| PT (1) | PT1051398E (es) |
| RU (1) | RU2220137C2 (es) |
| SI (1) | SI1051398T1 (es) |
| SK (1) | SK285109B6 (es) |
| TR (1) | TR200001936T2 (es) |
| TW (1) | TW552258B (es) |
| UA (1) | UA66832C2 (es) |
| UY (2) | UY25324A1 (es) |
| WO (1) | WO1999033803A1 (es) |
| ZA (1) | ZA9811817B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2395120T3 (es) * | 2006-12-20 | 2013-02-08 | Cardoz Ab | Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios |
| AU2007344274A1 (en) * | 2007-01-16 | 2008-07-24 | Cardoz Ab | New combination for use in the treatment of inflammatory disorders |
| WO2009007674A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast |
| CN101434571B (zh) * | 2007-11-13 | 2012-05-30 | 杭州容立医药科技有限公司 | 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法 |
| WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
| CN103054857A (zh) * | 2012-12-30 | 2013-04-24 | 北京阜康仁生物制药科技有限公司 | 一种以雷马曲班为活性成分的固体制剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3631824A1 (de) | 1986-02-21 | 1988-03-31 | Bayer Ag | Cycloalkano(1.2-b)indol-sulfonamide |
| CN1015711B (zh) * | 1986-02-21 | 1992-03-04 | 拜尔公司 | 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法 |
| DE19506739A1 (de) * | 1995-02-27 | 1996-08-29 | Bayer Ag | [3-Amino]-tetrahydrocarbazol-propansäureester |
-
1997
- 1997-12-24 DE DE19757983A patent/DE19757983A1/de not_active Withdrawn
-
1998
- 1998-12-09 HN HN1998000186A patent/HN1998000186A/es unknown
- 1998-12-11 AR ARP980106318A patent/AR013803A1/es unknown
- 1998-12-15 GT GT199800198A patent/GT199800198A/es unknown
- 1998-12-22 MY MYPI98005837A patent/MY116312A/en unknown
- 1998-12-22 PE PE1998001272A patent/PE20000115A1/es not_active Application Discontinuation
- 1998-12-23 CO CO98076459A patent/CO4970800A1/es unknown
- 1998-12-23 UY UY25324A patent/UY25324A1/es not_active IP Right Cessation
- 1998-12-23 TW TW087121479A patent/TW552258B/zh not_active IP Right Cessation
- 1998-12-23 ZA ZA9811817A patent/ZA9811817B/xx unknown
- 1998-12-24 BR BR9814496-0A patent/BR9814496A/pt not_active Application Discontinuation
- 1998-12-24 IN IN43MU2000 patent/IN192932B/en unknown
- 1998-12-24 IL IL13627898A patent/IL136278A/xx not_active IP Right Cessation
- 1998-12-24 US US09/582,250 patent/US6362214B1/en not_active Expired - Fee Related
- 1998-12-24 SK SK975-2000A patent/SK285109B6/sk unknown
- 1998-12-24 SI SI9830656T patent/SI1051398T1/xx unknown
- 1998-12-24 DK DK98961506T patent/DK1051398T3/da active
- 1998-12-24 DE DE69822882T patent/DE69822882T2/de not_active Expired - Fee Related
- 1998-12-24 JP JP2000526487A patent/JP3817668B2/ja not_active Expired - Lifetime
- 1998-12-24 WO PCT/JP1998/005844 patent/WO1999033803A1/en not_active Application Discontinuation
- 1998-12-24 ID IDW20001226A patent/ID25446A/id unknown
- 1998-12-24 CA CA002313230A patent/CA2313230A1/en not_active Abandoned
- 1998-12-24 HU HU0004432A patent/HUP0004432A3/hu unknown
- 1998-12-24 ES ES98961506T patent/ES2218874T3/es not_active Expired - Lifetime
- 1998-12-24 CN CNB98812405XA patent/CN1140510C/zh not_active Expired - Fee Related
- 1998-12-24 AU AU16874/99A patent/AU744242B2/en not_active Ceased
- 1998-12-24 PT PT98961506T patent/PT1051398E/pt unknown
- 1998-12-24 RU RU2000119741/04A patent/RU2220137C2/ru not_active IP Right Cessation
- 1998-12-24 PL PL98341359A patent/PL341359A1/xx not_active Application Discontinuation
- 1998-12-24 AT AT98961506T patent/ATE263152T1/de not_active IP Right Cessation
- 1998-12-24 UA UA2000074335A patent/UA66832C2/uk unknown
- 1998-12-24 KR KR1020007007031A patent/KR100586350B1/ko not_active IP Right Cessation
- 1998-12-24 NZ NZ504741A patent/NZ504741A/xx unknown
- 1998-12-24 TR TR2000/01936T patent/TR200001936T2/xx unknown
- 1998-12-24 EP EP98961506A patent/EP1051398B1/en not_active Expired - Lifetime
-
1999
- 1999-06-18 UY UY25575A patent/UY25575A1/es unknown
-
2000
- 2000-06-21 NO NO20003217A patent/NO316618B1/no unknown
- 2000-06-23 BG BG104554A patent/BG65024B1/bg unknown
-
2001
- 2001-07-27 HK HK01105260A patent/HK1034517A1/xx not_active IP Right Cessation
-
2005
- 2005-11-25 JP JP2005340586A patent/JP4411269B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003082853A8 (en) | New compounds | |
| WO2004055006A8 (en) | Novel compounds having selective inhibiting effect at gsk3 | |
| MX9700763A (es) | Procedimiento para la preparacion de benzoxazoles y derivados de piridinas utiles en el tratamiento de la diabetes del tipo ii, los benzoxazoles y derivados de piridina obtenidos, composiciones de los mismos y su uso. | |
| MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
| PT915898E (pt) | Forma i cristalina de claritromicina | |
| YU74500A (sh) | Novi derivat 3-aril-2-hidroksipropionske kiseline (i) | |
| NO20055766L (no) | Positive modulatorer av nikotinacetylcholinreseptorer | |
| WO2002032900A3 (en) | Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents | |
| PL392882A1 (pl) | Nowa krystaliczna i amorficzna postać związku triazolo(4,5-D) pirymidyny | |
| CA2368347A1 (en) | Glucokinase activators | |
| TW200740787A (en) | (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones | |
| ZA932168B (en) | Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them | |
| BR0015836A (pt) | Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp | |
| DE69229339T2 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
| HUT38950A (en) | Process for producing 2-substituted-1,3-propylidene-diphosphonate derivatives and pharmaceutical compositions containing them as active agents | |
| AR013803A1 (es) | Forma cristalina del acido (r)-3-[[(4-fluorfenil)sulfonil]amino]-1,2,3,4- tetrahidro-9h-carbazol-9-propanoico (ramatroban), proceso para su preparacion,su uso para la manufactura de un medicamento y medicamento que la contiene | |
| WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
| NZ216048A (en) | Quinolylglycinamide derivatives, and pharmaceutical compositions containing such | |
| NZ515108A (en) | Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| PT861250E (pt) | Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase | |
| HK1077303A1 (en) | Hexacyclic compounds | |
| HU9400784D0 (en) | Heterocyclic-substituted phenyl-cyclohexane-carboxylic acid derivatives, process for producing them and pharmaceutical compositions containing them | |
| YU70502A (sh) | Amorfna modifikacija torasemida | |
| RS4904A (en) | Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |